Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF V600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study).

Keitaro Shimozaki,Kenro Hirata,Taro Sato,Maho Nakamura,Kyoko Kato,Hidekazu Hirano,Yosuke Kumekawa,Kaori Hino,Kentaro Kawakami,Yosuke Kito,Toshihiko Matsumoto,Takeshi Kawakami,Masato Komoda,Kengo Nagashima,Yasunori Sato,Kentaro Yamazaki,Shuichi Hironaka,Hiromasa Takaishi,Yasuo Hamamoto,Kei Muro

Clinical colorectal cancer（2022）

Cited 0|Views17
No score
Abstract
Triplet therapy had no survival benefit versus doublet therapy in the overall and IPTW cohorts or specific subgroups for real-world patients with BRAF mutant mCRC.
More
Translated text
Key words
BRAF(V600E),Doublet,FOLFOXIRI,Metastatic colorectal cancer,TRIBE,Triplet
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined